The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for M Voegtle


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360.EBI
TBA
Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease.EBI
Novartis Pharma
Structure-Based and Property-Driven Optimization of EBI
Global Discovery Chemistry
Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors.EBI
Novartis Institutes For Biomedical Research
SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCERBDB
Astrazeneca
Process route of compound of formula (IV), crystal form and preparation method thereforBDB
Shandong Danhong Pharmaceutical Co.
Guanidine derivative and medical use thereofBDB
Toray Industries
Synthesis and biological evaluation of kojic acid derivatives containing 1,2,4-triazole as potent tyrosinase inhibitors.BDB
Hunan University of Science and Technology
Salvinorin derivatives and uses thereofBDB
The Mclean Hospital